Who it affects
- Federal agencies and their employees
- Employers covered by the optional guidance
- Department of Labor
In committeeHealth careWorkplace safety
WORK to Save Lives Act
S. 3812 · Senate bill · Introduced Feb. 10, 2026
The WORK to Save Lives Act would require federal agencies to stock opioid overdose reversal medication and train employees annually, while providing optional guidance for other employers.
What stands out
Loading…
These are patterns in public records, not proof that money changed a vote. The same rules apply to every member. How we decide
At a glance
Where it stands
In committee
How South Carolina voted
No recorded votes yet.
See each vote ↓Lobbying and money
No lobbying reported yet
Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.
What it would do
- The Labor Department would have 270 days after enactment to issue employer guidance and federal agency rules.
- Employer guidance would cover getting and maintaining opioid overdose reversal medication and training employees annually to use it.
- This guidance would be optional and would exclude the United States Postal Service.
- Federal agency rules would require stocking the medication and training employees annually to use it.
- These requirements would include the Veterans Health Administration.
Written with AI from the official bill text, because no CRS summary is available. Read the bill text ↗
How South Carolina voted
No recorded roll-call vote on this bill yet.
Groups that lobbied on it and gave to SC's members
PAC, lobbyist campaign and qualifying employee money this election, shown separately and never added together. Lobbying reports name the bills a group worked on, not which side it took.
No lobbying reported yet. Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.
Official record
Official title, sponsor and status
- Official title
- A bill to require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.
- Sponsor
- Sen. Merkley, Jeff (D-OR)
- Introduced
- Feb. 10, 2026
- Cosponsors
- 5
- Committees
- Senate Health, Education, Labor, and Pensions Committee
- Latest action
- March 19, 2026 · Committee on Health, Education, Labor, and Pensions. Hearings held.
Official summary from the Congressional Research Service
Congress hasn't published an official summary.
Summary on Congress.gov ↗Everyone who lobbied on this bill (0 groups)
No lobbying report we have loaded names this bill. That doesn't mean no lobbying took place.
Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published. Reports for October through December 2026 are due January 20, 2027.